Limited effect of patient and disease characteristics on compliance with hospital antimicrobial guidelines

European Journal of Clinical Pharmacology

Volumn 62, Issue 4, 2006, Pages 297-305

  Mol, Peter G M ^a   Denig, Petra ^a   Gans, Rijk O B ^a   NannanPanday, Prashant V ^a   Degener, John E ^a   Laseur, Marian ^a   Haaijer Ruskamp, Flora M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Antibiotic policy; Compliance; Drug therapy; Guidelines; Medical decision making

Indexed keywords

ALCOHOL; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; CIPROFLOXACIN; CREATININE; TOBRAMYCIN;

ABDOMINAL INFECTION; ADULT; ALCOHOLISM; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIUM CULTURE; BONE INFECTION; BRAIN INFECTION; BRONCHITIS; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYSTIC FIBROSIS; DISEASE PREDISPOSITION; ENTEROBACTER INFECTION; FEMALE; HOSPITAL INFECTION; HUMAN; INTRAVENOUS DRUG ABUSE; LOWER RESPIRATORY TRACT INFECTION; LUNG INFECTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL DECISION MAKING; MIXED INFECTION; MYCOSIS; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PYREXIA IDIOPATHICA; SEPSIS; SKIN INFECTION; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS INFECTION; UNIVERSITY HOSPITAL; URINARY TRACT INFECTION;

ANTI-INFECTIVE AGENTS; FEMALE; GUIDELINE ADHERENCE; HOSPITALS; HUMANS; INFECTION; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PRESCRIPTIONS, DRUG; PROSPECTIVE STUDIES;

EID: 33645681061     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-005-0058-y     Document Type: Article

References (41)

1. Gould IM (1999) A review of the role of antibiotic policies in the control of antibiotic resistance. J Antimicrob Chemother 43:459-465
2. Bartlett JG, Dowell SF, Mandell LA, File-Jr TM, Musher DM, Fine MJ (2000) Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis 31:347-382
3. Hatten J, Hughes M, Raymond CH (1994) Management of bacterial urinary tract infections in adults. Ann Pharmacother 28:1264-1272
4. Stamm WE, Hooton TM (1993) Management of urinary tract infections in adults. N Engl J Med 329:1328-1334
5. Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE (1999) Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis 29:745-758
6. Gyssens IC (2001) Quality measures of antimicrobial drug use. Int J Antimicrob Agents 17:9-19
7. Mandell GL, Douglas GD, Kelvin GV (2005) Mandell, Douglas, and Bennett's principles and practice of infectious diseases, 6th edn. Churchill Livingstone, Philadelphia
8. Fijn R, Chow M, Schuur PMH, et al (2002) Multicentre evaluation of prescribing concurrence with anti-infective guidelines: epidemiological assessment of indicators. Pharmacoepidemiol Drug Safety 11:361-372
9. Alvarez A, Gallego T, Garcia M, Gonzalez-Praetorius A, Martinez M, Molina M, Garcia F (2000) Influence of antibiotic susceptibility test results on the change of ciprofloxacin and ofloxacin-based treatments. EHP 6:54-57
10. Cobo J, Oliva J, Sanz J, Aguado JM, Del Pozo J, Moreno S (2003) Influence of microbiological reports on physician's choice of antimicrobial treatment for susceptible pathogens. Eur J Clin Microbiol Infect Dis 22:569-572
11. Bearden DT, Allen GP (2003) Impact of antimicrobial control programs on patient outcomes. Disease Manage Health Outcomes 11:723-736
12. Avorn J, Solomon DH (2000) Cultural and economic factors that (mis)shape antibiotic use: the nonpharmacologic basis of therapeutics. Ann Intern Med 133:128-135
13. Beek vdD, Gans de J, Spanjaard L, Vermeulen M, Dankert J (2002) Antibiotic guidelines and antibiotic use in adult bacterial meningitis in The Netherlands. J Antimicrob Chemother 49:661-666
14. McCaig DJ, Hind CA, Downie G, Wilkinson S (2000) Antibiotic use in elderly hospital inpatients before and after the introduction of treatment guidelines. Int J Pharm Pract 7:18-28
15. Brown EM (2002) Guidelines for antibiotic usage in hospitals. J Antimicrob Chemother 49:587-592
16. Grol R, Dalhuijsen J, Thomas S, Veld i'C, Rutten G, Mokkink H (1998) Attributes of clinical guidelines that influence use of guidelines in general practice: observational study. BMJ 317:858-861
17. Mol PGM, Wieringa JE, NannanPanday PN, Gans ROB, Degener JE, Laseur M, Haaijer-Ruskamp FM (2005) Improving compliance with hospital antibiotic guidelines: a time-series analysis. J Antimicrob Chemother 55:550-557
18. WHO collaborating centre for drug statistics methodology (2002) ATC Index with DDDs 2002. World Health Organization, Oslo
19. Antibiotica werkgroep UMCG (1999) Guidelines Antimicrobial Therapy and Prophylaxis 1999. University Medical Center Groningen, Netherlands. [Dutch title: Richtlijnen antimicrobiële therapie en profylaxe 1999]. UMCG, Groningen, Netherlands
20. Mol PGM, Gans ROB, NannanPanday PN, Degener JE, Laseur M, Haaijer-Ruskamp FM (2005) Reliability of assessment of adherence to an antimicrobial treatment guideline. J Hosp Infect 60:321-328
21. Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13:818-829
22. Atlas SJ, Benzer TI, Borowsky LH, Chang Y, Burnham DC, Metlay JP, Halm EA, Singer DE (1998) Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients: an interventional trial. Arch Intern Med 158:1350-1356
23. Meyer RJ, Town GI, Harre E, Koning M, Hurrell M, Beard ME, Chambers ST (1997) An audit of the assessment and management of adults admitted to Christchurch Hospital with community acquired pneumonia. N Z Med J 110:349-352
24. Cook PP, Catrou PG, Christie JD, Young PD, Polk RE (2004) Reduction in broad-spectrum antimicrobial use associated with no improvement in hospital antibiogram. J Antimicrob Chemother 53:853-859
25. European Antimicrobial Resistance Surveillance System (2001) EARSS Annual Report 2000. Bilthoven, The Netherlands, RIVM
26. Centers for Disease Control (2002) Campaign to prevent antimicrobial resistance in healthcare settings http://www.cdc.gov/drugresistance/healthcare/ ha/12steps_HA.htm, accessed October 2005
27. Mol PGM, Rutten WJMJ, Gans ROB, Degener JE, Haaijer-Ruskamp FM (2004) Adherence barriers to antimicrobial treatment guidelines in teaching hospital, the Netherlands. Emerg Infect Dis 10:522-525
28. Wenzel RP (2002) Treating sepsis. N Engl J Med 347:966-967
29. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH (2000) The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118:146-155
30. Kasteren van ME, Wijnands WJ, Stobberingh EE, Janknegt R, van der Meer JW (1998) Optimaliseren van het antibioticabeleid in Nederland. II. SWAB-richtlijnen voor antimicrobiele therapie bij thuis opgelopen pneumonie en bij nosocomiale pneumonie. [Optimization of the antibiotics policy in the Netherlands. II. SWAB guidelines for the antimicrobial therapy of pneumonia in patients at home and as nosocomial infections. The Netherlands Antibiotic Policy Foundation]. Ned Tijdschr Geneeskd 142:952-956
31. Bronzwaer SL, Cars O, Buchholz U, Molstad S, Goettsch W, Veldhuijzen IK, Kool JL, Sprenger MJ, Degener JE (2002) A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 8:278-282
32. Kasteren van ME, Stobberingh EE, Janknegt R, Wijnands WJ, van der Meer JW (1999) Optimaliseren van het antibioticabeleid in Nederland. IV. SWAB-richtlijnen voor antimicrobiele therapie in het ziekenhuis bij volwassenen met sepsis. [Optimizing the antibiotics policy in the Netherlands. IV. SWAB- guidelines for antimicrobial therapy of adults with sepsis in hospitals. Foundation Antibiotics Policy Work Group]. Ned Tijdschr Geneeskd 143:611-617
33. Buijk SE, Mouton JW, Gyssens IC, Verbrugh HA, Bruining HA (2002) Experience with a once-daily dosing program of aminoglycosides in critically ill patients. Intensive Care Med 28:936-942
34. Aleva RM, Boersma WG, Cox AL, Haren van EHJ, Schreurs AJM, Wijnands WJA, Dekhuijzen PNR (2001) Concept guideline on community-acquired pneumonia. [In Dutch: Richtlijn "Community-acquired" pneumonie (CAP)]. NVALT
35. Kasje W, Denig P, Haaijer-Ruskamp FM (2002) Specialists' expectations regarding joint treatment guidelines for primary and secondary care. Int J Qual Health Care 14:509-518
36. Livermore DM, James D, Reacher M, Graham C, Nichols T, Stephens P, Johnson AP, George RC (2002) Trends in fluoroquinolone (ciprofloxacin) resistance in Enterobacteriaceae from bacteremias, England and Wales, 1990-1999. Emerg Infect Dis 8:473-478
37. Goettsch W, van Pelt W, Nagelkerke N, Hendrix MG, Buiting AG, Petit PL, Sabbe LJ, van Griethuysen AJ, De Neeling AJ (2000) Increasing resistance to fluoroquinolones in escherichia coli from urinary tract infections in the Netherlands. J Antimicrob Chemother 46:223-228
38. Denig P, Witteman CLM, Schouten HW (2002) Scope and nature of prescribing decisions made by general practicioners. Quality Health Care 11:137-143
39. Haaren van KM, Visser HS, Vliet van S, Timmermans EA, Yavada R, Geerlings SE, Riet ter G, Pinxteren van B (2005) NHG Standaard Urineweginfecties, tweede herziening. [In Dutch] Dutch College of General Practicioners Guideline for urinary tract infections, 2nd update. Dutch College of General Practicioners http://nng.artsennet.nl/uri/?uri=AMGATE_6059_104_TICH_R158763570837883, accessed October 2005
40. Fijn R, De-Jong-Van-den-Berg-LTW, Brouwers JRBJ (1999) Rational pharmacotherapy in the Netherlands: formulary management in Dutch hospitals. Pharm World Sci 21:2-79
41. Janknegt R (1994) Antibiotic policy in Dutch hospitals [thesis]. Catholic University Nijmegen, Netherland